|
Sign In to gain access to subscriptions and/or personal tools.
|
Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis
V L Stevenson
NMR Research Unit, Institute of Neurology, Queen Square, London, WC1N 3BG, UK
D H Miller
NMR Research Unit, Institute of Neurology, Queen Square, London, WC1N 3BG, UK
Disease progression and irreversible disability in multiple sclerosis results from incomplete recovery from relapses, but most importantly from insidious disease progression. Although magnetic resonance imaging parameters, such as new lesion rate and gadolinium enhancement, reflect inflammation and disease activity they have no bearing on disease progression. Until now the T2 lesion load or disease burden has been relied upon for this, despite its poor relationship with disability measures. This paper looks at the mechanisms responsible for disease progression and discusses the MR techniques now available to reflect these pathological processes.
Key Words: multiple sclerosis magnetic resonance imaging
Multiple Sclerosis, Vol. 5, No. 4,
268-272 (1999)
DOI: 10.1177/135245859900500413

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology,
May 29, 2007;
68(22_suppl_3):
S22 - S31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Oh, R G Henry, C Genain, S J Nelson, and D Pelletier
Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
J. Neurol. Neurosurg. Psychiatry,
September 1, 2004;
75(9):
1281 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis,
June 1, 2004;
10(1_suppl):
S23 - S30.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis,
May 1, 2004;
10(3_suppl):
S23 - S30.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M Wilson, C R Tench, P S Morgan, and L D Blumhardt
Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability
J. Neurol. Neurosurg. Psychiatry,
February 1, 2003;
74(2):
203 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Melhem, E. H. Herskovits, K. Karli-Oguz, X. Golay, D. A. Hammoud, B. J. Fortman, F. M. Munter, and R. Itoh
Defining Thresholds for Changes in Size of Simulated T2-Hyperintense Brain Lesions on the Basis of Qualitative Comparisons
Am. J. Roentgenol.,
January 1, 2003;
180(1):
65 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Arnold and P.M. Matthews
MRI in the diagnosis and management of multiple sclerosis
Neurology,
April 23, 2002;
58(90084):
S23 - 31.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen
Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
March 1, 2002;
23(3):
371 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Wilson, P S Morgan, X Lin, B P Turner, and L D Blumhardt
Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
March 1, 2001;
70(3):
318 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Phillips
Rethinking Multiple Sclerosis
Arch Neurol,
January 1, 2001;
58(1):
30 - 32.
[Full Text]
[PDF]
|
 |
|
|
|